Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma. | Endocrine | 2022 | 35947334 | PubTator, text mining | PubMed |
| Patterns of structural variation define prostate cancer across disease states. | JCI Insight | 2022 | 35943799 | PubTator, text mining | PubMed |
| RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS. | Genes Immun | 2022 | 35941292 | PubTator, text mining | PubMed |
| Emerging Roles of Circ-ZNF609 in Multiple Human Diseases. | Front Genet | 2022 | 35938040 | PubTator, text mining | PubMed |
| Application of Cell-Derived Extracellular Vesicles and Engineered Nanovesicles for Hair Growth: From Mechanisms to Therapeutics. | Front Cell Dev Biol | 2022 | 35912106 | PubTator, text mining | PubMed |
| Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma. | Int J Mol Sci | 2022 | 35887382 | PubTator, text mining | PubMed |
| Altered Transcriptional Regulation of Glycolysis in Circulating CD8+ T Cells of Rheumatoid Arthritis Patients. | Genes (Basel) | 2022 | 35886000 | PubTator, text mining | PubMed |
| Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review. | J Exp Clin Cancer Res | 2022 | 35864520 | PubTator, text mining | PubMed |
| ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. | Front Immunol | 2022 | 35860243 | PubTator, text mining | PubMed |
| A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. | Neuropathology | 2022 | 35859319 | PubTator, text mining | PubMed |
| Mutant KRAS regulates transposable element RNA and innate immunity via KRAB zinc-finger genes. | Cell Rep | 2022 | 35858545 | PubTator, text mining | PubMed |
| Latest developments in the pathobiology of Ewing sarcoma. | J Bone Oncol | 2022 | 35855933 | PubTator, text mining | PubMed |
| Left Atrial Cardiomyopathy - A Challenging Diagnosis. | Front Cardiovasc Med | 2022 | 35845077 | PubTator, text mining | PubMed |
| Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes. | Mol Neurodegener | 2022 | 35842725 | PubTator, text mining | PubMed |
| Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma. | Acta Neuropathol Commun | 2022 | 35836290 | PubTator, text mining | PubMed |
| ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2. | Int J Med Sci | 2022 | 35813298 | PubTator, text mining | PubMed |
| Positional weight matrices have sufficient prediction power for analysis of noncoding variants. | F1000Res | 2022 | 35811788 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion. | Cancers (Basel) | 2022 | 35804898 | PubTator, text mining | PubMed |
| FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits. | Cancer Res | 2022 | 35802025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=21